ArticleBiomedical engineering letters2025
Alzheimer's disease recognition based on waveform and spectral speech signal processing.
Article in Biomedical engineering letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder with an irreversible progression. Currently, it is diagnosed using invasive and costly methods, such as cerebrospinal fluid analysis, neuroimaging, and neuropsychological assessments. Recent studies indicate that certain changes in language ability can predict early cognitive decline, highlighting the potential of speech analysis in AD recognition. Based on this premise, this study proposes an AD recognition multi-channel network framework, which is referred to as the ADNet. It integrates both time-domain and frequency-domain features of speech signals, using waveform images and log-Mel spectrograms derived from raw speech as data sources. The framework employs inverted residual blocks to enhance the learning of low-level time-domain features and uses gated multi-information units to effectively combine local and global frequency-domain features. The study tests it on a dataset from the Shanghai cognitive screening (SCS) digital neuropsychological assessment. The results show that the method we proposed outperforms existing speech-based methods, achieving an accuracy of 88.57%, a precision of 88.67%, and a recall of 88.64%. This study demonstrates that the proposed framework can effectively distinguish between the AD and normal controls, and it may be useful for developing early recognition tools for AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.